Takashi Shirakura

1.3k total citations
14 papers, 1.0k citations indexed

About

Takashi Shirakura is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Takashi Shirakura has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Epidemiology. Recurrent topics in Takashi Shirakura's work include Gout, Hyperuricemia, Uric Acid (5 papers), Inflammasome and immune disorders (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Takashi Shirakura is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (5 papers), Inflammasome and immune disorders (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Takashi Shirakura collaborates with scholars based in Japan, United States and Switzerland. Takashi Shirakura's co-authors include Mizuho Tamura, Ryuichi Moriya, Junko Itô, Satoshi Mashiko, Toru Seo, Chieko Matsui, Jun Suzuki, Akio Kanatani, Hiroyasu Hirose and Hitoshi Nishizawa and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Takashi Shirakura

14 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Shirakura Japan 12 377 347 296 241 223 14 1.0k
Xiongzhong Ruan China 22 217 0.6× 268 0.8× 609 2.1× 179 0.7× 72 0.3× 45 1.3k
Min Young Kim South Korea 12 173 0.5× 262 0.8× 353 1.2× 120 0.5× 59 0.3× 15 958
Eun Nim Kim South Korea 14 170 0.5× 305 0.9× 468 1.6× 104 0.4× 88 0.4× 22 1.2k
M D Nyby United States 17 601 1.6× 203 0.6× 353 1.2× 313 1.3× 319 1.4× 29 1.5k
Harvest F. Gu China 24 145 0.4× 170 0.5× 565 1.9× 319 1.3× 42 0.2× 75 1.5k
Sally A. Penfold Australia 17 357 0.9× 222 0.6× 590 2.0× 669 2.8× 154 0.7× 24 1.9k
Konstantinos Paletas Greece 17 63 0.2× 494 1.4× 300 1.0× 311 1.3× 99 0.4× 35 1.2k
Klaus Höcherl Germany 23 232 0.6× 136 0.4× 398 1.3× 253 1.0× 47 0.2× 39 1.3k
David Legouis Switzerland 16 266 0.7× 155 0.4× 307 1.0× 56 0.2× 70 0.3× 34 963
Philip M. Scherer United States 6 81 0.2× 317 0.9× 163 0.6× 202 0.8× 63 0.3× 10 751

Countries citing papers authored by Takashi Shirakura

Since Specialization
Citations

This map shows the geographic impact of Takashi Shirakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Shirakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Shirakura more than expected).

Fields of papers citing papers by Takashi Shirakura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Shirakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Shirakura. The network helps show where Takashi Shirakura may publish in the future.

Co-authorship network of co-authors of Takashi Shirakura

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Shirakura. A scholar is included among the top collaborators of Takashi Shirakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Shirakura. Takashi Shirakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nagata, Naoto, Tetsuro Shimakami, Takashi Shirakura, et al.. (2020). Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice. Scientific Reports. 10(1). 815–815. 57 indexed citations
2.
Shirakura, Takashi, Chisayo Kozuka, Masato Yonamine, et al.. (2018). Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study. Journal of Diabetes Investigation. 10(1). 94–103. 35 indexed citations
3.
Shirakura, Takashi, et al.. (2018). FP422A NOVEL XANTHINE OXIDOREDUCTASE INHIBITOR TMX-049ATTENUATES RENAL INJURY IN ALBUMIN OVERLOAD INDUCED−NEPHROPATHY. Nephrology Dialysis Transplantation. 33(suppl_1). i177–i177. 1 indexed citations
4.
Shirakura, Takashi, et al.. (2017). MP493NOVEL XANTHINE OXIDASE INHIBITOR TEI-B AMELIORATES URINARY ALBUMIN EXCRETION IN NORMOURICEMIC DIABETIC KIDNEY DISEASE MODELS. Nephrology Dialysis Transplantation. 32(suppl_3). iii609–iii609. 1 indexed citations
5.
Honorat, Josephe A., Yuji Nakatsuji, Makoto Kinoshita, et al.. (2017). Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner. PLoS ONE. 12(11). e0187215–e0187215. 18 indexed citations
6.
Shirakura, Takashi, Johji Nomura, Chieko Matsui, et al.. (2016). Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(8). 831–838. 29 indexed citations
7.
Nomura, Johji, Nathalie Busso, Annette Ives, et al.. (2014). Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice. Scientific Reports. 4(1). 4554–4554. 145 indexed citations
8.
Tsushima, Yu, Hitoshi Nishizawa, Yoshihiro Tochino, et al.. (2013). Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity. Journal of Biological Chemistry. 288(38). 27138–27149. 299 indexed citations
9.
Honorat, Josephe A., Makoto Kinoshita, Tatsusada Okuno, et al.. (2013). Xanthine Oxidase Mediates Axonal and Myelin Loss in a Murine Model of Multiple Sclerosis. PLoS ONE. 8(8). e71329–e71329. 41 indexed citations
10.
Moriya, Ryuichi, Takashi Shirakura, Junko Itô, Satoshi Mashiko, & Toru Seo. (2009). Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. American Journal of Physiology-Endocrinology and Metabolism. 297(6). E1358–E1365. 135 indexed citations
11.
Moriya, Ryuichi, Takashi Shirakura, Hiroyasu Hirose, et al.. (2009). NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides. 31(4). 671–675. 24 indexed citations
12.
Moriya, Ryuichi, Toru Fujikawa, Junko Itô, et al.. (2009). Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice. European Journal of Pharmacology. 627(1-3). 258–264. 19 indexed citations
13.
Ito, Makoto, Jun Suzuki, Minoru Sasaki, et al.. (2007). Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet. Hepatology Research. 37(1). 50–57. 185 indexed citations
14.
Shirakura, Takashi, Feng Han, Shigeki Moriguchi, et al.. (2005). Inhibition of Nitric Oxide Production and Protein Tyrosine Nitration Contribute to Neuroprotection by a Novel Calmodulin Antagonist, DY-9760e, in the Rat Microsphere Embolism. Biological and Pharmaceutical Bulletin. 28(9). 1658–1661. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiongzhong Ruan Breakdown of academic impact, for papers by Min Young Kim Breakdown of academic impact, for papers by Eun Nim Kim Breakdown of academic impact, for papers by M D Nyby Breakdown of academic impact, for papers by Harvest F. Gu Breakdown of academic impact, for papers by Sally A. Penfold Breakdown of academic impact, for papers by Konstantinos Paletas Breakdown of academic impact, for papers by Klaus Höcherl Breakdown of academic impact, for papers by David Legouis Breakdown of academic impact, for papers by Philip M. Scherer
Rankless by CCL
2026